In March 2024, WIXBIO welcomed a delegation from Alaq, Al-Shaheen Co. for Trading of Veterinary Medicines, Pesticides, and Agriculture Supplies Ltd (from now on referred to as Alaq, Al-Shaheen Co.). (from now on referred to as Alaq, Al-Shaheen Company). The delegation, which included the company’s Managing Director, Dr. Osamah, and officials from the Ministry of Agriculture, Dr. Hasan and Dr. Rabab, visited the company to conduct a factory inspection of WIXBIO’s production facilities and discuss future strategic cooperation.
As an essential trading company of animal vaccines, pesticides, and agricultural supplies in Iraq and the Middle East, Alaq, Al-Shaheen has long been committed to providing high-quality products and services to the local farming industry. The visit was the first in-depth exchange between the two parties. It signaled significant progress in WIXBIO’s strategic goal of expanding into international markets, especially in the Middle East and North Africa.
In-depth exchanges demonstrate WIXBIO’s strength. On the visit day, WIXBIO warmly received the delegation from Alaq, Al-Shaheen, and arranged a detailed tour of the company. Dr Osamah and the team visited WIXBIO’s R&D laboratory and production plant, focusing on the company’s technological strengths in animal vaccine research and development, production, and quality control. The WIXBIO technical team explained every aspect of vaccine production in detail. The team explained in detail every essential step of vaccine production, from raw material procurement, production formulation, R&D testing, and final quality inspection, to ensure that every batch of vaccine meets international standards.
Dr. Hasan and Dr. Rabab also paid particular attention to WIXBIO’s technology and vaccine cold chain management capability. They learned how the company ensures that the vaccines are always stored at optimal temperatures during transport to maximize their effectiveness and safety.
Both parties reached a vital consensus. During the subsequent business negotiation, WIXBIO and Alaq Al-Shaheen discussed the direction of future cooperation. Both parties agreed that with the growing demand for animal vaccines in the Middle East, the cooperation would promote the further expansion of the two companies in R&D, production, and vaccine customization services. Alaq, Al-Shaheen highly recognized WIXBIO’s expertise and technological innovations in vaccines, and Dr. Osamah said:’ WIXBIO’s advanced technology and strict quality control system give us confidence in our future cooperation. We believe that through the collaboration between the two parties, we can bring more high-quality products and solutions to the animal vaccine market in Iraq and the whole Middle East region.’
Factory inspection passed successfully, opening a new chapter of cooperation. After completing a comprehensive inspection of the production facilities, Alaq Al-Shaheen confirmed that WIXBIO’s production standards and quality management system meet the international certification requirements and successfully pass the factory inspection assessment. This lays a solid foundation for future in-depth cooperation in vaccine production and customized services.
The successful passing of this factory inspection proves our technical strength and product quality in animal vaccines and opens up new opportunities for further expansion in the Middle East market,’ said the head of WIXBIO. We look forward to working hand in hand with Alaq and Al-Shaheen to provide more vaccine solutions suitable for Iraq and the neighboring regions.’
Looking to the future, a promising collaboration As WIXBIO’s presence in the global market continues to grow, the company will continue to strengthen its cooperation with international customers and increase its investment in R&D in animal vaccines. In the future, WIXBIO will provide more targeted vaccine products and services according to the market needs of different regions, helping the sustainable development of global animal health.
